Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study

C. Gallois, E. S. Bergen, Auclin, S. Pernot, J. Higué, I. Trouilloud, Y. Touchefeu, A. Turpin, T. Mazard, A. Sartore-Bianchi, H. Prenen, A. Alberti, L. Pilla, S. Cuissy, V. Wookey, A. Perret, C. Melchior, P. Artru, O. Dubreuil, A. DrouillardS. Doat, J. Lavolé, D. Basile, G. Perkins, M. Jary, S. Stintzing, J. Jos, D. Tougeron, J. Taieb

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science